1. Home
  2. CCNE vs DCTH Comparison

CCNE vs DCTH Comparison

Compare CCNE & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCNE
  • DCTH
  • Stock Information
  • Founded
  • CCNE 1865
  • DCTH 1988
  • Country
  • CCNE United States
  • DCTH United States
  • Employees
  • CCNE N/A
  • DCTH 76
  • Industry
  • CCNE Major Banks
  • DCTH Medical/Dental Instruments
  • Sector
  • CCNE Finance
  • DCTH Health Care
  • Exchange
  • CCNE Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • CCNE 455.3M
  • DCTH 426.3M
  • IPO Year
  • CCNE N/A
  • DCTH N/A
  • Fundamental
  • Price
  • CCNE $23.79
  • DCTH $11.52
  • Analyst Decision
  • CCNE Hold
  • DCTH Strong Buy
  • Analyst Count
  • CCNE 1
  • DCTH 4
  • Target Price
  • CCNE $26.00
  • DCTH $24.00
  • AVG Volume (30 Days)
  • CCNE 75.6K
  • DCTH 850.4K
  • Earning Date
  • CCNE 07-21-2025
  • DCTH 08-04-2025
  • Dividend Yield
  • CCNE 2.97%
  • DCTH N/A
  • EPS Growth
  • CCNE N/A
  • DCTH N/A
  • EPS
  • CCNE 2.34
  • DCTH N/A
  • Revenue
  • CCNE $219,886,000.00
  • DCTH $53,850,000.00
  • Revenue This Year
  • CCNE $17.91
  • DCTH $155.42
  • Revenue Next Year
  • CCNE $27.71
  • DCTH $37.93
  • P/E Ratio
  • CCNE $10.35
  • DCTH N/A
  • Revenue Growth
  • CCNE 1.97
  • DCTH 1068.87
  • 52 Week Low
  • CCNE $19.32
  • DCTH $7.17
  • 52 Week High
  • CCNE $29.29
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • CCNE 65.00
  • DCTH 32.83
  • Support Level
  • CCNE $23.94
  • DCTH $12.11
  • Resistance Level
  • CCNE $24.44
  • DCTH $14.15
  • Average True Range (ATR)
  • CCNE 0.46
  • DCTH 0.57
  • MACD
  • CCNE 0.16
  • DCTH -0.16
  • Stochastic Oscillator
  • CCNE 82.93
  • DCTH 9.67

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: